Amicus Therapeutics, Inc. (FOLD) Social Stream



Amicus Therapeutics, Inc. (FOLD): $11.96

0.30 (-2.45%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add FOLD to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#31 of 360

in industry

AMICUS THERAPEUTICS INC (FOLD) Price Targets From Analysts

Use the tables below to see what analysts covering AMICUS THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 11 $29 $12 $18.333 $12.26 49.54%
2021-11-15 10 $29 $12 $18.444 $12.26 50.44%
2021-11-23 9 $29 $12 $17.5 $12.26 42.74%
2022-01-13 9 $29 $12 $17.375 $12.26 41.72%
2022-01-17 9 $29 $15 $17.875 $12.26 45.8%
2022-01-26 9 $29 $15 $17.5 $12.26 42.74%
2022-02-25 9 $29 $14 $17 $12.26 38.66%
2022-04-20 9 $20 $14 $15.5 $12.26 26.43%
2022-05-10 10 $20 $11 $15 $12.26 22.35%
2022-05-12 8 $20 $11 $15.125 $12.26 23.37%
2022-08-05 7 $20 $11 $15.285 $12.26 24.67%
2022-08-13 7 $20 $11 $15.142 $12.26 23.51%
2022-10-19 8 $20 $11 $15 $12.26 22.35%
2022-11-07 8 $20 $11 $15.125 $12.26 23.37%
2022-11-15 8 $20 $11 $15.428 $12.26 25.84%
2023-01-16 8 $20 $11 $15.375 $12.26 25.41%
2023-02-08 8 $20 $11 $15.875 $12.26 29.49%
2023-03-03 9 $20 $11 $16.111 $12.26 31.41%
2023-04-12 9 $20 $11 $16.222 $12.26 32.32%
2023-07-11 8 $20 $11 $16.111 $12.26 31.41%
2023-08-09 8 $20 $11 $16.222 $12.26 32.32%
2023-08-10 8 $20 $11 $16.333 $12.26 33.22%
2023-08-16 8 $20 $11 $16.444 $12.26 34.13%

The Trend in the Analyst Price Target


FOLD's average price target has moved down $1.06 over the prior 21 months.

FOLD reports an average of 33.25% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-29 8 20 11 15.375 12.09 27.17%
2023-04-12 9 20 11 16.222 11.05 46.81%
2023-05-01 8 20 11 16.111 11.90 35.39%
2023-05-10 8 20 11 16.111 11.58 39.13%
2023-08-10 8 20 11 16.333 13.28 22.99%

FOLD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 7 0 1 0 0 8

The Trend in the Broker Recommendations


FOLD's average broker recommendation rating improved by 0.35 over the prior 21 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • AMICUS THERAPEUTICS INC's average analyst price target is higher than 586.65% of all US stocks.
  • FOLD has a lower variance in analysts' estimates than -2006.32% of all US stocks.
  • In the context of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 616.2% of them.
  • In the context of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's number of analysts covering the stock is greater than 1838.46% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMICUS THERAPEUTICS INC are CORT, INVA, and ACAD.

What is the outlook for FOLD? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!